FR1578703A - - Google Patents

Info

Publication number
FR1578703A
FR1578703A FR1578703DA FR1578703A FR 1578703 A FR1578703 A FR 1578703A FR 1578703D A FR1578703D A FR 1578703DA FR 1578703 A FR1578703 A FR 1578703A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1578703A publication Critical patent/FR1578703A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1578703D 1963-02-18 1964-02-17 Expired FR1578703A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6460/63A GB1067421A (en) 1963-02-18 1963-02-18 Derivatives of rifamycin b
BE643965A BE643965A (fr) 1963-02-18 1964-02-18

Publications (1)

Publication Number Publication Date
FR1578703A true FR1578703A (fr) 1969-08-22

Family

ID=25655699

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1578703D Expired FR1578703A (fr) 1963-02-18 1964-02-17
FR974507A Active FR3457M (fr) 1963-02-18 1964-05-14 Nouveaux médicaments dérivés de la rifamycine b a acion antibiotique.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR974507A Active FR3457M (fr) 1963-02-18 1964-05-14 Nouveaux médicaments dérivés de la rifamycine b a acion antibiotique.

Country Status (9)

Country Link
US (1) US3197468A (fr)
BE (1) BE643965A (fr)
BR (1) BR6456843D0 (fr)
CH (1) CH421131A (fr)
DE (1) DE1227027B (fr)
FR (2) FR1578703A (fr)
GB (1) GB1067421A (fr)
NL (2) NL6401440A (fr)
SE (1) SE330023B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8802211D0 (en) * 1988-02-02 1988-03-02 Lepetit Spa Teicoplanin hydrazides
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
WO2005034857A2 (fr) * 2003-09-05 2005-04-21 Sequella, Inc. Procedes et compositions renfermant des diamines comme nouveaux produits therapeutiques antituberculeux
KR100964330B1 (ko) * 2005-07-07 2010-06-17 학교법인 포항공과대학교 당흡수 조절제 및 당뇨병 또는 당뇨병 합병증의 치료방법
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Also Published As

Publication number Publication date
CH421131A (fr) 1966-09-30
DE1227027B (de) 1966-10-20
BE643965A (fr) 1964-06-15
FR3457M (fr) 1965-07-26
US3197468A (en) 1965-07-27
BR6456843D0 (pt) 1973-08-14
GB1067421A (en) 1967-05-03
SE330023B (fr) 1970-11-02
NL126233C (fr)
NL6401440A (fr) 1964-08-19

Similar Documents

Publication Publication Date Title
AT260747B (fr)
BE627012A (fr)
BE608372A (fr)
BE31062A (fr)
BE462764A (fr)
BE465565A (fr)
BE507458A (fr)
BE533484A (fr)
BE547422A (fr)
BE571209A (fr)
BE582314A (fr)
BE603935A (fr)
BE627025A (fr)
BE612803A (fr)
BE614220A (fr)
BE616247A (fr)
BE616830A (fr)
BE616967A (fr)
BE619061A (fr)
BE620325A (fr)
BE621232A (fr)
BE621517A (fr)
BE622160A (fr)
BE623117A (fr)
BE623220A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse